DUBLIN–(BUSINESS WIRE)–The “Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System Component, Type of Buffer Formulation, Type of Molecule, Type of Compatible Biologic, Type of Buffer Packaging, Geographical Regions and Leading Players” report has been added to ResearchAndMarkets.com’s offering.
The buffer preparation market size is currently valued at USD 8.58 billion and is projected to reach 17.96 billion by 2035, growing at a CAGR of 7.8% during the forecast period.
Buffers play a role in numerous upstream and downstream bioprocesses for different purposes, including improving the yield of target products, ensuring consistent purification conditions, and stabilizing the end product while preserving its functional properties.
Traditional pharmaceutical buffer production face numerous challenges that affect their manufacturing processes, leading to elevated production expenses and inconsistencies between batches of final products. Thus, the incorporation of an innovative buffer production system in their manufacturing plants is necessary, owing to intricate processes and limited resources or the need to contract pharmaceutical buffer production to external service providers.
Moreover, outsourcing the production of pharmaceutical buffers minimizes the requirement for large facilities and significant capital investment, while also simplifying the intricate logistics associated with buffer production and storage. In the past few years, the production of buffers and buffer management systems has quickly become popular. These systems actively incorporate cutting-edge technologies to preserve the physiological conditions of buffers throughout downstream processes. Additionally, the increasing need for buffers and the difficulties related to conventional buffer production are expected to propel market expansion in buffer manufacturing in the years to come.
North America is likely to capture the majority share (~40%) in the overall market currently, and this trend is unlikely to change in the future. It is important to note that companies based in North America are progressively implementing buffer production systems to lower manufacturing expenses, enhance efficiency, and ensure high-quality batch products. Additionally, the companies provide tailored buffer preparation services for research laboratories and industries. Further, the market in Asia-Pacific is likely to grow at a high CAGR (8%), during the forecast period.
Buffer Preparation Market: Key Segments
Commercial Scale Holds the Largest Share in the Overall Buffer Preparation Market
Within the buffer manufacturing systems market in the current year, the commercial scale segment is likely to capture the maximum share (~85%) and this trend is likely to remain the same in the coming years. This results from the expanding pipeline of biopharmaceutical products, significant investment in research and development, and technological developments, which creates a demand for advanced buffer preparation solutions in pharmaceutical production.
Reusable Buffer Mixing / Preparation Equipment Leads the Buffer Preparation Market
Estimates suggest that the reusable buffer mixing / preparation equipment market segment is likely to capture the majority share (~80%) in the overall market in the current year and is likely to grow at a relatively faster rate during the forecast period.
Liquid Formulation Captures the Largest Share
Currently, the liquid formulations segment is likely to capture the maximum share (~70%); further, this trend is likely to remain the same in the future as well. This is due to liquid buffers providing consistency between batches and ultimately minimizing the chance of human mistakes in buffer production.
Small Molecules Holds the Largest Share in the Current Year
Currently, the small molecules segment is likely to capture the maximum share (~75%); further, this trend is likely to remain the same in the future as well. This is due to the extensive therapeutic potential of small molecules and the rising occurrence of chronic illnesses, which is boosting the demand for greater drug production, consequently heightening the need for buffers in manufacturing.
Currently, Antibodies Segment Captures Majority of the Buffer Preparation Market Share
In the current year, the antibodies segment is likely to capture the maximum share (~55%) of the overall market; further, this trend is likely to remain the same in the future as well. The cell and gene therapies segment will grow at a significantly higher CAGR (19.5%) throughout the forecast period.
Bottles Segment Captures the Majority of the Market Share
The bottles segment captures the majority share (~40%) in the overall market in the current year and is likely to dominate the market in the future as well.
Buffer Preparation Market: Key Insights
- Around 60 buffer manufacturing systems are currently available in the market for stabilizing drug components in biopharmaceuticals; notably, most of these buffer systems are offered by players based in the US.
- 86% of the buffer manufacturing systems are fabricated using stainless steel; interestingly, 95% of the buffer systems work automatically with various controls for pH, conductivity, temperature and pressure.
- Stakeholders are actively enhancing their existing capabilities and strengthening their product portfolios in order to gain a competitive edge in the industry and comply with evolving industry standards.
- More than 70 companies are offering buffer manufacturing services for different packaging formats; further, close to 55% of the buffer manufacturing service providers are based in North America.
- Over 60% of the firms engaged in this domain manufacture custom buffers; notably, most of these buffers have been formulated as liquid bottles.
- In pursuit of gaining a competitive edge and to meet the evolving industry requirements, stakeholders are actively enhancing their existing buffer manufacturing capabilities by improving their respective service portfolios.
- The growing interest of stakeholders in buffer manufacturing is evident from the partnership activity in the recent past; in fact, close to 20% of the total deals have been signed in the last two years.
- The global buffer manufacturing systems market is anticipated to grow at a steady pace in coming years; majority of the share is captured by buffer manufacturing systems intended for commercial scale manufacturing.
- Most of the buffer manufacturing services market is captured by small molecules owing to their broad therapeutic applicability; cell and gene therapies segment is likely to grow at a CAGR of 19.5%.
Reasons to Buy this Report
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
Buffer preparation market: Research Coverage
- Market Sizing and Opportunity Analysis
- Buffer Manufacturing Systems Market Landscape
- Product Competitiveness Analysis
- Company Profiles
- Buffer Manufacturing Service Providers Market Landscape
- Company Competitiveness Analysis
- Partnerships and Collaborations
Players in the Buffer Preparation Market, Profiled in the Report Include:
- Asahi Kasei
- Avantor
- Canvax
- Danaher
- GE Healthcare
- HOPAX
- Merck
- Prepared Biologics
- Sartorius
- Sepragen
- Thermo Fisher Scientific
- ZETA
Report Segmentation
Scale of Operation
- Preclinical / Clinical
- Commercial
Type of System Component
- Single-use Buffer Mixing / Preparation Equipment
- Reusable Buffer Mixing / Preparation Equipment
Type of Buffer Formulation
- Liquid
- Powder
Type of Molecule
- Small Molecules
- Biologics
Type of Compatible Biologic
- Antibodies
- Vaccines
- Proteins / Peptides
- Cell and Gene Therapies
- Other Biologics
Type of Buffer Packaging
- Antibodies
- Vaccines
- Proteins / Peptides
- Cell and Gene Therapies
- Other Biologics
Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
Additional Benefits
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 15% Free Content Customization
- Detailed Report Walkthrough Session with Research Team
- Free Updated report if the report is 6-12 months old or older
For more information about this report visit https://www.researchandmarkets.com/r/vlag37
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900